Baxter To Exit Drug Price Inflation MDL For $30M
Baxter Healthcare Corp. on Friday reached a $29.8 million settlement in Massachusetts with the relator in multidistrict litigation accusing pharmaceutical companies of reporting inflated average wholesale prices of drugs to Medicaid...To view the full article, register now.
Already a subscriber? Click here to view full article